Page last updated: 2024-11-13

n-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1h-indazole-3-carboxamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide: a street drug; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID86567422
SCHEMBL ID17600563
MeSH IDM000608041

Synonyms (11)

Synonym
n-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1h-indazole-3-carboxamide
3kip69ynqk ,
unii-3kip69ynqk
1445583-20-9
1h-indazole-3-carboxamide, n-(1-(aminocarbonyl)-2-methylpropyl)-1-pentyl-
ab-pinaca, (+/-)-
SCHEMBL17600563
Q26840858
n-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-3-indazolecarboxamide
n-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1h-indazole-3-carboxamide
DTXSID901153033
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (80.00)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies4 (26.67%)4.05%
Observational0 (0.00%)0.25%
Other9 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]